CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPO

Positive
AI Analysis

Summary

Ratio Therapeutics raised $70M in Series C funding from existing investors including Bristol Myers Squibb and new investors for radiopharmaceutical trials. Separately, Vogenx plans a $67M IPO.

Importance:5/10
Sentiment:
0.60
radiopharmaceuticalSeries C fundingRatio TherapeuticsIPOVogenxBristol Myers Squibb
Related Companies

Read the original article

Published by Endpoints News on July 31, 2026 2:59 PM

Read Original